Ping Zheng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ping Zheng has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Blair A. Jobe
Esophageal and Lung Institute, Allegheny Health Network, Pittsburgh, USA
1 shared publication - Inanc Samil Sarici
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA
1 shared publication - Olivia Bs Moore
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA
1 shared publication - Shahin Ayazi
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States; Chevalier Jackson Esophageal Research Center, Western Pennsylvania Hospital, Pittsburgh, PA, United States; Department of Surgery, Drexel University, Philadelphia, PA, United States
1 shared publication - Sven E. Eriksson
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA
1 shared publication
Latest Publications
- Open Access
- 23 February 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 454-461
Impact of Change in Sizing Protocol on Outcome of Magnetic Sphincter Augmentation
Objective: To evaluate and compare magnetic sphincter augmentation (MSA) device sizing protocols on postoperative outcomes and dysphagia. Background: Among predictors of dysphagia after MSA, device size is the only factor that may be modified. Many centers have adopted protocols to increase device size. However, there are limited data on the impact of MSA device upsizing protocols on surgical outcomes. Methods: Patients who underwent MSA were implanted with 2 or 3 beads above the sizing device’s pop-off point (POP). Clinical and objective outcomes >1 year after surgery were compared between patients implanted with POP+2-versus-POP+3 sizing protocols. Multiple subgroups were analyzed for the benefit of upsizing. Preoperative and postoperative characteristics were compared between the size patients received, regardless of protocol. Results: A total of 388 patients were implanted under POP+2 and 216 under POP+3. At a mean of 14.2 (7.9) months, pH normalization was 73.6% and 34.1% required dilation, 15.9% developed persistent dysphagia, and 4.0% required removal. The sizing protocol had no impact on persistent dysphagia (P=0.908), pH normalization (P=0.822), or need for dilation (P=0.210) or removal (P=0.191). Subgroup analysis found that upsizing reduced dysphagia in patients with 5000 (0% vs 30.4%, P=0.034). Regardless of sizing protocol, as device size increased there was a stepwise increase in the percent male sex (P30 (P3 cm (PPPPP=0.043) or removal (P=0.014). Conclusions: Upsizing from POP+2 to POP+3 does not reduce dysphagia or affect other MSA outcomes; however, patients with poor peristalsis or hypercontractile esophagus do benefit. Regardless of sizing protocol, preoperative clinical characteristics varied among device sizes, suggesting size is not a modifiable factor, but a surrogate for esophageal circumference.
- 23 February 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 454-461
Open AccessImpact of Change in Sizing Protocol on Outcome of Magnetic Sphincter Augmentation
Objective: To evaluate and compare magnetic sphincter augmentation (MSA) device sizing protocols on postoperative outcomes and dysphagia. Background: Among predictors of dysphagia after MSA, device size is the only factor that may be modified. Many centers have adopted protocols to increase device size. However, there are limited data on the impact of MSA device upsizing protocols on surgical outcomes. Methods: Patients who underwent MSA were implanted with 2 or 3 beads above the sizing device’s pop-off point (POP). Clinical and objective outcomes >1 year after surgery were compared between patients implanted with POP+2-versus-POP+3 sizing protocols. Multiple subgroups were analyzed for the benefit of upsizing. Preoperative and postoperative characteristics were compared between the size patients received, regardless of protocol. Results: A total of 388 patients were implanted under POP+2 and 216 under POP+3. At a mean of 14.2 (7.9) months, pH normalization was 73.6% and 34.1% required dilation, 15.9% developed persistent dysphagia, and 4.0% required removal. The sizing protocol had no impact on persistent dysphagia (P=0.908), pH normalization (P=0.822), or need for dilation (P=0.210) or removal (P=0.191). Subgroup analysis found that upsizing reduced dysphagia in patients with 5000 (0% vs 30.4%, P=0.034). Regardless of sizing protocol, as device size increased there was a stepwise increase in the percent male sex (P30 (P3 cm (PPPPP=0.043) or removal (P=0.014). Conclusions: Upsizing from POP+2 to POP+3 does not reduce dysphagia or affect other MSA outcomes; however, patients with poor peristalsis or hypercontractile esophagus do benefit. Regardless of sizing protocol, preoperative clinical characteristics varied among device sizes, suggesting size is not a modifiable factor, but a surrogate for esophageal circumference.